GENERIC ASSAYS FOR DETECTION OF INFLUENZA VIRUSES
The invention relates to generic methods for the detection and quantification of influenza viruses. These may use a reverse transcription (RT-PCR) real time (q-PCR) assay which amplifies a conserved region within influenza A or B strains The assays allow the quantification of influenza virus RNA molecules or whole virus particles, irrespective of the particular virus strain (e.g. human, avian, swine flu). The methods are particularly applicable as diagnostic assays or in the monitoring of vaccine production processes.
1 . (canceled)
2 . The method according to claim 7 , wherein the conserved region codes partly or completely for the M protein.
3 . The method according to claim 7 , wherein the method provides an amplicon comprising SEQ ID NO 3 or SEQ ID NO 9.
4 . The method according to claim 7 wherein the amplification comprises a one-step RT-qPCR.
5 . The method according to claim 4 , wherein at least one primer or probe used in the one-step RT-qPCR is selected from SEQ ID NOs 1-11.
6 . (canceled)
7 . A method for quantifying the amount of intact virus particles in a sample comprising the following steps:
a) the free virus RNA is removed from the sample
b) a method for detecting remaining influenza virus RNA in the sample is applied comprising amplification of a conserved region within the influenza genome,
c) the signal generated in part (b) is compared to the signal generated by a standard RNA, and
d) the amount of intact virus particles is quantified.
8 - 9 (canceled)
10 . A method for production of influenza virus comprising a fermentation step of a cell culture based influenza virus production process, wherein the amount of influenza virus particle is quantified during the fermentation step using the method of claim 7 to determine the optimal time for harvesting the influenza viruses.
11 . A method for the cell culture-based production of an influenza vaccine, comprising the following steps:
propagating cells in a fermentation vessel;
adding seed influenza viruses;
monitoring the virus propagation using the method of claim 7 ;
centrifuging and filtering the virus suspension;
purifying the virus by chromatography and ultra-/diafiltration steps, inactivating the virus, disrupting the virus to solubilize the viral surface antigens HA and NA;
filtering the antigens to obtain monovalent bulk; and
filling into final container.
12 . The method according to claim 10 , further comprising blending the monovalent bulk into multivalent bulks before filling.
13 - 16 . (canceled)
17 . The method according to claim 2 , wherein the amplification comprises a one-step RT-qPCR.
18 . The method according to claim 10 , wherein the conserved region codes partly or completely for the M protein.
19 . The method according to claim 10 , wherein the method provides an amplicon comprising SEQ ID NO 3 or SEQ ID NO 9.
20 . The method according to claim 10 , wherein the amplification comprises a one-step RT-qPCR.
21 . The method according to claim 20 , wherein at least one primers or probes used in the one-step RT-qPCR is selected from SEQ ID NOs 1-11.
22 . The method according to claim 18 , wherein the amplification comprises a one-step RT-qPCR.
23 . The method according to claim 11 , wherein the conserved region codes partly or completely for the M protein.
24 . The method according to claim 11 , wherein the method provides an amplicon comprising SEQ ID NO 3 or SEQ ID NO 9.
25 . The method according to claim 11 , wherein the amplification comprises a one-step RT-qPCR.
26 . The method according to claim 25 , wherein at least one primers or probes used in the one-step RT-qPCR is selected from SEQ ID NOs 1-11.
27 . The method according to claim 23 , wherein the amplification comprises a one-step RT-qPCR.